Roivant Sciences (ROIV) Income towards Parent Company (2020 - 2024)

Roivant Sciences has reported Income towards Parent Company for 5 years, with the latest figure at $327.0 million in Q4 2024.

• For the quarter ending Q4 2024, Income towards Parent Company rose 661.1% year-over-year to $327.0 million; the trailing twelve-month figure through Sep 2025 stood at $327.0 million (up 2764.77% YoY), and the FY2025 full-year result was $373.2 million, up 218.93% from the prior year.
• Income towards Parent Company for Q4 2024 stood at $327.0 million, up from -$43.1 million in the prior quarter.
• The five-year high for Income towards Parent Company was $327.0 million in Q4 2024, with the low at -$384.9 million in Q4 2022.
• Historically, Income towards Parent Company has averaged -$141.6 million across 5 years, with a median of -$101.1 million in 2021.
• Annual changes were most pronounced in 2021 — Income towards Parent Company tumbled 1167.12% — and 2024, when it jumped 661.1%.
• Roivant Sciences' Income towards Parent Company stood at -$275.6 million in 2020, then slipped by 11.06% to -$306.1 million in 2021, then decreased by 25.75% to -$384.9 million in 2022, then jumped by 84.86% to -$58.3 million in 2023, then jumped by 661.1% to $327.0 million in 2024.
• The last three Income towards Parent Company figures came in at $327.0 million (Q4 2024), -$43.1 million (Q3 2024), and $89.1 million (Q2 2024), per Business Quant data.